Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors

被引:6
作者
Zhang, Zheng [1 ,2 ,3 ,4 ]
Wang, Fei [1 ,2 ,3 ,4 ]
Li, Zheng [1 ,2 ,3 ,4 ]
Ye, Zeng [1 ,2 ,3 ,4 ]
Zhuo, Qifeng [1 ,2 ,3 ,4 ]
Xu, Wenyan [1 ,2 ,3 ,4 ]
Liu, Wensheng [1 ,2 ,3 ,4 ]
Liu, Mengqi [1 ,2 ,3 ,4 ]
Fan, Guixiong [1 ,2 ,3 ,4 ]
Qin, Yi [1 ,2 ,3 ,4 ]
Zhang, Yue [5 ]
Chen, Xuemin [5 ]
Yu, Xianjun [1 ,2 ,3 ,4 ]
Xu, Xiaowu [1 ,2 ,3 ,4 ]
Ji, Shunrong [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, 270 DongAn Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
[5] First Peoples Hosp Changzhou, Changzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lymph node metastasis; Lymphadenectomy; Pancreatic neuroendocrine tumors; ENETS CONSENSUS GUIDELINES; LYMPH-NODE METASTASES; ENDOCRINE TUMORS; PROGNOSTIC-FACTORS; SURGERY; PREDICTORS; SURVIVAL; IMPACT; KI-67; NEOPLASMS;
D O I
10.1186/s12893-022-01595-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Although some factors that predict the prognosis in pancreatic neuroendocrine tumor (pNET) have been confirmed, the predictive value of lymph node metastasis (LNM) in the prognosis of pNETs remains conflicting and it is not clear whether regional lymphadenectomy should be performed in all grades of tumors. Methods We included pNET patients undergoing surgery in Shanghai pancreatic cancer institute (SHPCI). The risk factors for survival were investigated by the Kaplan-Meier method and Cox regression model. We evaluated the predictors of LNM using Logistic regression. Results For 206 patients in the SHPCI series, LNM was an independent prognostic factor for entire cohort suggested by multivariate Cox regression analysis. LNM (P = 0.002) predicted poorer overall survival (OS) in grade 2/3 cohort, but there is no significant association between LNM and OS in grade 1 cohort. Grade (P < 0.001) and size (P = 0.049) predicted LNM in entire cohort. Grade (P = 0.002) predicted LNM while regardless of size in grade 2/3 cohort. Conclusions Based on our own retrospective data obtained from a single center series, LNM seems to be associated with poorer outcome for patients with grade 2/3 and/or grade 1 > 4 cm tumors. On the other way, LNM was seems to be not associated with prognosis in patients with grade 1 tumors less than 4 cm. Moreover, tumor grade and tumor size seem to act as independent predictors of LNM. Thus, regional lymphadenectomy should be performed in grade 2/3 patients but was not mandatory in grade 1 tumors < 4 cm. It is reasonable to perform functional sparing surgery for grade 1 patients or propose a clinical-radiological monitoring.
引用
收藏
页数:9
相关论文
共 41 条
  • [1] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
    Amin, Mahul B.
    Greene, Frederick L.
    Edge, Stephen B.
    Compton, Carolyn C.
    Gershenwald, Jeffrey E.
    Brookland, Robert K.
    Meyer, Laura
    Gress, Donna M.
    Byrd, David R.
    Winchester, David P.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 93 - 99
  • [2] Lymphadenectomy in pancreatic neuroendocrine neoplasms: Why are we still debating?
    Ausania, F.
    Senra del Rio, P.
    [J]. PANCREATOLOGY, 2018, 18 (08) : 855 - 861
  • [3] A simplified prognostic system for resected pancreatic neuroendocrine neoplasms
    Ballian, Nikiforos
    Loeffler, Agnes G.
    Rajamanickam, Victoria
    Norstedt, Peter A.
    Weber, Sharon M.
    Cho, Clifford S.
    [J]. HPB, 2009, 11 (05) : 422 - 428
  • [4] Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors
    Barenboim, Alex
    Lahat, Guy
    Nachmany, Ido
    Nakache, Richard
    Goykhman, Yaakov
    Geva, Ravit
    Osher, Ester
    Scapa, Erez
    Wolf, Ido
    Orbach, Lior
    Brazowski, Eli
    Isakov, Ofer
    Klausner, Joseph M.
    Lubezky, Nir
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (06) : 1366 - 1374
  • [5] Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors - Analysis of 3851 patients
    Bilimoria, Karl Y.
    Talamonti, Mark S.
    Tomlinson, James S.
    Stewart, Andrew K.
    Winchester, David P.
    Ko, Clifford Y.
    Bentrem, David J.
    [J]. ANNALS OF SURGERY, 2008, 247 (03) : 490 - 500
  • [6] Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification
    Brunner, Stefan M.
    Weber, Florian
    Werner, Jens M.
    Agha, Ayman
    Farkas, Stefan A.
    Schlitt, Hans J.
    Hornung, Matthias
    [J]. BMC SURGERY, 2015, 15
  • [7] The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas
    Capretti, G.
    Nappo, G.
    Smiroldo, V
    Cereda, M.
    Branciforte, B.
    Spaggiari, P.
    Carrara, S.
    Preatoni, P.
    Gavazzi, F.
    Ridolfi, C.
    Donisi, G.
    Lania, A.
    Zerbi, A.
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [8] Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
    Dasari, Arvind
    Shen, Chan
    Halperin, Daniel
    Zhao, Bo
    Zhou, Shouhao
    Xu, Ying
    Shih, Tina
    Yao, James C.
    [J]. JAMA ONCOLOGY, 2017, 3 (10) : 1335 - 1342
  • [9] Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis
    Drymousis, Panagiotis
    Raptis, Dimitri A.
    Spalding, Duncan
    Fernandez-Cruz, Laureano
    Menon, Deepak
    Breitenstein, Stefan
    Davidson, Brian
    Frilling, Andrea
    [J]. HPB, 2014, 16 (05) : 397 - 406
  • [10] ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
    Falconi, M.
    Eriksson, B.
    Kaltsas, G.
    Bartsch, D. K.
    Capdevila, J.
    Caplin, M.
    Kos-Kudla, B.
    Kwekkeboom, D.
    Rindi, G.
    Kloeppel, G.
    Reed, N.
    Kianmanesh, R.
    Jensen, R. T.
    [J]. NEUROENDOCRINOLOGY, 2016, 103 (02) : 153 - 171